Annals of Oncology

Editorials:

R. Stupp and B. G. Baumert

Promises and controversies in the management of low-grade glioma
Ann Oncol 14: 1695-1696; doi:10.1093/annonc/mdg501
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

A. Jones

Combining trastuzumab (Herceptin^®) with hormonal therapy in breast cancer: what can be expected and why?
Ann Oncol 14: 1697-1704; doi:10.1093/annonc/mdg483
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

F. Graziano, B. Humar, and P. Guilford

The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice
Ann Oncol 14: 1705-1713; doi:10.1093/annonc/mdg486
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Brain tumors:

M. Brada, L. Viviers, C. Abson, F. Hines, J. Britton, S. Ashley, S. Sardell, D. Traish, A. Gonsalves, P. Wilkins, and C. Westbury

Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas
Ann Oncol 14: 1715-1721; doi:10.1093/annonc/mdg371
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Pace, A. Vidiri, E. Galiè, M. Carosi, S. Telera, A. M. Cianciulli, P. Canalini, D. Giannarelli, B. Jandolo, and C. M. Carapella

Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response
Ann Oncol 14: 1722-1726; doi:10.1093/annonc/mdg502
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. A. Brandes, U. Basso, F. Vastola, A. Tosoni, L. M. Pasetto, A. Jirillo, S. Lonardi, M. K. Paris, H. Koussis, S. Monfardini, and M. Ermani

Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study
Ann Oncol 14: 1727-1731; doi:10.1093/annonc/mdg494
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. J. van den Bent, W. Grisold, D. Frappaz, R. Stupp, J. P. Desir, T. Lesimple, C. Dittrich, M. J. A. de Jonge, A. Brandes, M. Frenay, A. F. Carpentier, P. Chollet, J. Oliveira, B. Baron, D. Lacombe, M. Schuessler, and P. Fumoleau

European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme
Ann Oncol 14: 1732-1734; doi:10.1093/annonc/mdg491
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gastrointestinal tumors:

W. Scheithauer, J. McKendrick, S. Begbie, M. Borner, W. I. Burns, H. A. Burris, J. Cassidy, D. Jodrell, P. Koralewski, E. L. Levine, N. Marschner, J. Maroun, P. Garcia-Alfonso, J. Tujakowski, G. Van Hazel, A. Wong, J. Zaluski, and C. Twelves

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial
Ann Oncol 14: 1735-1743; doi:10.1093/annonc/mdg500
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Breast cancer:

J. M. Watters, J. C. Yau, K. O’Rourke, E. Tomiak, and S. Z. Gertler

Functional status is well maintained in older women during adjuvant chemotherapy for breast cancer
Ann Oncol 14: 1744-1750; doi:10.1093/annonc/mdg497
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

M. Binn, A. Ruskoné-Fourmestraux, E. Lepage, C. Haioun, A. Delmer, P. Aegerter, A. Lavergne, C. Guettier, and J.-C. Delchier

Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma
Ann Oncol 14: 1751-1757; doi:10.1093/annonc/mdg495
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. Wöhrer, J. Drach, M. Hejna, W. Scheithauer, A. Dirisamer, A. Püspök, A. Chott, and M. Raderer

Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP)
Ann Oncol 14: 1758-1761; doi:10.1093/annonc/mdg492
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

T. Baetz, A. Belch, S. Couban, K. Imrie, J. Yau, R. Myers, K. Ding, N. Paul, L. Shepherd, J. Iglesias, R. Meyer, and M. Crump

Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group
Ann Oncol 14: 1762-1767; doi:10.1093/annonc/mdg496
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Rodríguez, M. D. Caballero, A. Gutiérrez, J. Marín, J. J. Lahuerta, A. Sureda, E. Carreras, A. León, R. Arranz, A. Fernández de Sevilla, J. Zuazu, J. García-Laraña, J. Rifon, R. Varela, M. Gandarillas, J. SanMiguel, and E. Conde

High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience
Ann Oncol 14: 1768-1775; doi:10.1093/annonc/mdg459
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

C. Mita, E. Chatelut, M. Bekradda, P. Soulié, P. Canal, J.-L. Misset, E. Cvitkovic, and R. Bugat

Phase I and pharmacological study of an oxaliplatin and carboplatin combination in advanced malignancies
Ann Oncol 14: 1776-1782; doi:10.1093/annonc/mdg490
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. P. Venook, C. Enders Klein, G. Fleming, D. Hollis, C. G. Leichman, R. Hohl, J. Byrd, D. Budman, M. Villalona, J. Marshall, G. L. Rosner, J. Ramirez, H. Kastrissios, and M. J. Ratain

A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863
Ann Oncol 14: 1783-1790; doi:10.1093/annonc/mdg493
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

A. Zabernigg, R. Schranzhofer, A. Kreczy, and K. Gattringer

Continuously elevated cardiac troponin I in two patients with multiple myeloma and fatal cardiac amyloidosis
Ann Oncol 14: 1791; doi:10.1093/annonc/mdg487
[Extract] [FREE Full Text] [PDF] [Request Permissions]

B. Hellerstedt and A. Ahmed

Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment
Ann Oncol 14: 1792; doi:10.1093/annonc/mdg488
[Extract] [FREE Full Text] [PDF] [Request Permissions]

R. Gastaldi, P. Martino, G. Gentile, M. S. De Propris, M. F. Pirillo, A. De Vellis, and F. Mandelli

High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin’s lymphoma with or without antiretroviral therapy during antineoplastic agents
Ann Oncol 14: 1792-1794; doi:10.1093/annonc/mdg484
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Z. Sirotovà, A. Tartarone, M. Aieta, F. Morelli, and S.S. Toma

Role and limits of salvage chemotherapy in breast cancer patients treated with high-dose chemotherapy
Ann Oncol 14: 1794-1795; doi:10.1093/annonc/mdg485
[Extract] [FREE Full Text] [PDF] [Request Permissions]

S. Monfardini, A. Jirillo, M. Boscaro, M. Galeazzo, and O. Pitocchi

Can the ISO9000 quality assessment be applied to the practice of medical oncology?
Ann Oncol 14: 1795; doi:10.1093/annonc/mdg489
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

R. Marais

D.M. Terrian, G.M. Cencetti (eds). Cancer Cell Signaling: Methods and Protocols
Ann Oncol 14: 1797; doi:10.1093/annonc/mdg499
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.